<DOC>
	<DOCNO>NCT00006294</DOCNO>
	<brief_summary>To examine whether association select hypertensive gene combine fatal coronary heart disease nonfatal myocardial infarction high-risk hypertensive modify type antihypertensive treatment , lead differential risk coronary heart disease .</brief_summary>
	<brief_title>GenHAT -- Genetics Hypertension Associated Treatments</brief_title>
	<detailed_description>BACKGROUND : The study might shed important light variation patient response antihypertensive agent , improve ability pick right antihypertensive specific patient . GenHAT ancillary study ALLHAT ( Antihypertensive Lipid-Lowering Treatment Prevent Heart Attack Trial ) . ALLHAT recruit 42,515 hypertensive randomize one four antihypertensive agent ( lisinopril , chlorthalidone , amlodipine , doxazosin ) ; follow-up complete March , 2002 . DESIGN NARRATIVE : GenHAT , prospective study ancillary ALLHAT , characterize hypertension genetic variant determine interaction antihypertensive treatment relation coronary heart disease ( CHD ) . DNA frozen clot store ALLHAT Central Laboratory use genotype variant hypertension gene ( angiotensinogen -6 , angiotensin convert enzyme insertion/deletion , angiotensin type- 1 receptor , alpha-adducin , beta2 adrenergic receptor , lipoprotein lipase , 10 new hypertension variant expect discovered course study ) . In addition primary aim , number secondary aim undertaken evaluate gene- treatment interaction relation endpoint , include all-cause mortality , stroke , heart failure , leave ventricular hypertrophy , decrease renal function , peripheral arterial disease , blood pressure lower . Because ethnic gender diversity ALLHAT , assessment make effect variant outcomes key subgroup ( age &gt; 65 year , woman , African Americans , Type II diabetic ) , whether gene-treatment interaction relation outcomes consistent across subgroup .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<criteria>No eligibility criterion</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>